Regencell Bioscience Holdings Limited
RGC
Rang in aandelen
#3465
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Aandeelprijs
$9.83
Marktkapitalisatie
$4.88B
Verandering (1 dag)
-8.96%
Verandering (1 jaar)
-37.57%
Land
HK
Handel Regencell Bioscience Holdings Limited (RGC)
Categorie
Healthcare
Koersgeschiedenis voor Regencell Bioscience Holdings Limited (RGC)
Hoogste slotkoers: $8.34 op 2026-10-01
Laagste slotkoers: $0.24 op 2021-07-01
Laagste slotkoers: $0.24 op 2021-07-01
Koersgeschiedenis van Regencell Bioscience Holdings Limited van 2021 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -1.78% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
